a2 Milk on trading halt after surging on report of U.S. FDA nod for baby formula

A2 Milk

02/08/2022 06:44

** ASX-listed shares of dairy firm a2 Milk Co  A2M.AX 
climbed as much as 11.9% to A$5.080 before trading was halted
    ** A2M jumped on a media report that it would get U.S. FDA
approval to sell baby formula in the United States as soon as
this week (https://bit.ly/3cZ9URM)
    ** A2M clarifies that while its FDA application is
under active review, "at this stage there is no certainty as to
the outcome of the application or the timing"  urn:newsml:reuters.com:*:nL4N2ZE1AR
    ** A2M touched its highest level since April 8 and was the
top gainer on the ASX 200 benchmark index  .AXJO 
    ** NZ-listed shares  ATM.NZ  also rise as much as 12.2% to
NZ$4.89 before being halted 
    ** As of last close, A2M is down 16.9% this year, while
NZ-listed ATM is down 15.9%

 (Reporting by Himanshi Akhand in Bengaluru)
 ((Himanshi.Akhand@thomsonreuters.com;))